About Revvity, Inc. 
Revvity, Inc.
Pharmaceuticals & Biotechnology
PerkinElmer Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. Its Discovery & Analytical Solutions segment serves the life sciences and applied markets. Through the Diagnostics Segment, it offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals. It provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its product under various brands, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, FragilEase, Genoglyphix, GSP, PG-Seq, PG-Find, Protein Clear, ProteinEXact and QSight, Glutomatic, Honigs Regression, HyperDSC, Inframatic, LAMBDA, NexION, NEN, OneSource, Opera Phenix, Operetta CLS and OsteoSense.
Company Coordinates 
Company Details
155 Federal St Ste 700 , BOSTON MA : 02110-1727
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 103 Schemes (57.41%)
Foreign Institutions
Held by 281 Foreign Institutions (24.63%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Alexandros Michas
Independent Non-Executive Chairman of the Board
Mr. Prahlad Singh
President, Chief Executive Officer, Director
Dr. Peter Barrett
Independent Director
Mr. Samuel Chapin
Independent Director
Dr. Sylvie Gregoire
Independent Director
Mr. Michel Vounatsos
Independent Director
Revenue and Profits:
Net Sales:
720 Million
(Quarterly Results - Jun 2025)
Net Profit:
55 Million
Pharmaceuticals & Biotechnology
USD 10,015 Million (Small Cap)
33.00
NA
0.34%
0.29
4.20%
1.33






